Smyca-FOXM1 ribonucleoprotein complex promotes homologous recombination and tumor immune evasion to define a therapeutic target of triple-negative breast cancer

Overview of attention for article published in Journal of Biomedical Science, August 2026

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

news: 2 news outlets
blogs: 1 blog

twitter: 3 X users

Readers on

mendeley: 1 Mendeley

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,346 followers.

RT @IBCSinica: 🔬Publication - by Dr. Ruey-Hwa Chen The long non-coding #RNA #Smyca is highly expressed in TNBC. It binds #FOXM1 to promote…

🔬Publication - by Dr. Ruey-Hwa Chen The long non-coding #RNA #Smyca is highly expressed in TNBC. It binds #FOXM1 to promote homologous recombination, suggesting Smyca as a potential target for sensitizing TNBC to #chemotherapy, #PARPi, or #immunotherapy.…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity.